yahoo_financeOriginal article
Mirum's Q2 Earnings Lag Estimates, Revenues Beat, 2026 View Raised
EarningsPositive
AI Analysis
Summary
Mirum Pharmaceuticals reported Q2 earnings with EPS lagging estimates but revenues beating expectations, while raising its 2026 guidance outlook.
Financial Highlights
Guidance
2026 view raised
Outcome Details
Q2 earnings per share lagged estimates; revenues beat estimates; 2026 guidance raised
Importance:5/10
Sentiment:
0.30
earningsrevenue_beateps_missguidance_raised
Related Companies
Read the original article
Published by yahoo_finance on August 6, 2026 3:21 PM